Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
US group revises down upper end of full-year revenue estimates
Read more at Financial Times
-
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
Business - CNBC - 1 hour ago -
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Business - CNBC - October 15 -
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
Top stories - NBC News - October 16 -
Chipotle misses revenue estimates as same-store sales growth disappoints
Business - CNBC - 8 hours ago -
ASML share plunge wipes over $50 billion off Dutch chip giant's value
Business - CNBC - October 16 -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Business - MarketWatch - 2 hours ago
More from Financial Times
-
Business and wealthy bear brunt of £40bn tax increases in UK Budget
Business - Financial Times - 2 hours ago -
UK Budget as it happened: Rachel Reeves raises tax, spending and borrowing
Business - Financial Times - 13 hours ago -
The Budget in brief: what you need to know
Business - Financial Times - 1 hour ago -
UK hits wealthy with raids on non-doms, private equity and estates
Business - Financial Times - 3 hours ago -
Reeves’ first Budget leaves key economic challenges unresolved
Business - Financial Times - 1 hour ago
Latest in Business
-
Meta misses on user growth, warns of 2025 jump in AI spending
Business - CNBC - 10 minutes ago -
Coinbase shares tumble as muted crypto trading leads to a third-quarter miss
Business - CNBC - 11 minutes ago -
Starbucks will stop charging extra for dairy substitutes
Business - CNBC - 13 minutes ago -
CDC says 90 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
Business - CNBC - 14 minutes ago -
Harvard Business School professor says this is the No. 1 'misconception about failing'
Business - CNBC - 17 minutes ago